Skip to content

A Randomized Blinded Trial of Abscess Management With Packing vs No Packing

A Randomized Blinded Trial of Abscess Management With Packing vs No Packing

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01698996
Enrollment
0
Registered
2012-10-03
Start date
2013-03-31
Completion date
Unknown
Last updated
2015-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Uncomplicated Cutaneous Abscess

Keywords

abscess, packing, emergency medicine, wound care, incision and drainage

Brief summary

Adult patients presenting to the emergency department with superficial cutaneous abscesses will be randomized after incision and drainage to standard care with wound packing or no packing to determine if there is a difference in the proportion of complications between the two groups.

Interventions

PROCEDUREPacking vs No Packing

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 18 years * Abscess ≤ 5cm in diameter * Truncal or extremity location

Exclusion criteria

* Post-operative abscess (abscess in location of operative incision, operation within the last 4 months) * HIV/immunocompromised/transplant recipient/chronic oral steroid use * Fever at triage (temp ≥38 degrees Celsius) * Abscess secondary to Crohn's * Multiple abscesses requiring drainage * Prior participation in the study for the same abscess * Incision and drainage performed with no packing required, or where abscess cavity is \<1 cm max diameter * Bartholins/perigenital, perianal, or facial abscesses * Complicated abscesses (fistula, suspicion of muscular extension, consultation/direct referral to general surgery) * Inability to give consent

Design outcomes

Primary

MeasureTime frame
Proportion of complications (defined as a composite of the following: need for repeat incision and drainage by physician, need for admission to hospital, or need for escalation to intravenous antibiotics)7 days

Secondary

MeasureTime frame
Proportion of wounds closed at 1 week (wound size <0.5 cm length and depth and no drainage)7 days

Other

MeasureTime frame
Proportion of wounds closed at 2 weeks (wound size <0.5 cm length and depth and no drainage)14 days
Pain scores (daily pain scores for first week from patient diary)7 days
Amount of Pain Medication Used7 days
Resources Utilized14 days

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026